Human platelets express two distinct G protein-coupled ADP receptors, one c
oupled to phospholipase C through Gq, P2Y1, and the other to inhibition of
adenylyl cyclase through Gi, P2T(AC). We have recently shown that concomita
nt intracellular signaling from both the P2T(AC) and P2Y1 receptors is esse
ntial for ADP-induced platelet aggregation. Previous studies have tested wh
ether ADP causes a decrease in the basal cAMP level and this reduction prom
otes platelet aggregation, but did not study the effect of decreased cAMP I
evels when the Gq pathway is selectively activated. Since we are now aware
that platelet aggregation requires activation of two receptors, we investig
ated whether the function of P2T(AC) receptor activation, leading to inhibi
tion of platelet adenylyl cyclase, could be replaced by direct inhibition o
f adenylyl cyclase, when Gq pathway is also activated, a possibility that h
as not been addressed to date,In the present study, we supplemented the P2Y
1 mediated Gq signaling pathway with inhibition of the platelet adenylyl cy
clase by using SQ22536 or dideoxyadenosine, or by selective activation of t
he alpha(2A) adrenoceptors with epinephrine. Although SQ22536, dideoxyadeno
sine, and epinephrine reduced the cAMP levels, only epinephrine could mimic
the P2T(AC) receptor mediated signaling events, suggesting that reduction
in basal cAMP levels does not directly contribute to ADP-induced platelet a
ctivation. Adenosine-5'-phosphate-3'-phosphosulfate, a P2Y1 receptor antago
nist, completely blocked ADP-induced inositol 1,4,5-trisphosphate and inosi
tol 1,3,4-trisphosphate formation suggesting that P2T(AC)-mediated activati
on of G(i) (or other G proteins) does not activate phospholipase C. These r
esults suggest that a signaling event downstream from Gi, independent of th
e inhibition of platelet adenylyl cyclase, contributes to alpha(IIb)beta(3)
activation.